S4698Referred to Committee

A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-06-08
Introduced
1
Cosponsors
S
Type

Sponsor

Ron Johnson
Ron Johnson
Republican · WI · Senator
Votes with party: 73.2% (820 recorded votes)
Top industries funding sponsor:
  • Conservative Groups$1,456k

Full profile: /officials/J000293

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-06-08

Source: Congress.gov

Committee Activity

Plain-English Summary

This bill would allow patients with serious or life-threatening illnesses to try experimental medical treatments that haven't yet been officially approved by the FDA, even if those treatments are still being tested. The change would give terminally ill or severely sick patients more options when standard treatments aren't working, though they would need to work with their doctors to access these experimental therapies. The bill affects patients with life-threatening conditions, their doctors, and pharmaceutical companies developing new treatments.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.

Related legislation

Bills by the same sponsor or covering overlapping subjects.